{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:07:31Z","timestamp":1777284451762,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"National Institute of Mental Health of the National Institutes of Health","award":["R01MH095905"],"award-info":[{"award-number":["R01MH095905"]}]},{"name":"Rappaport Mental Health Research Scholar Award"},{"name":"McLean Presidential Fellowship Award"},{"name":"National Alliance for Research on Schizophrenia and Depression Young Investigator Award"},{"name":"Eleanor and Miles Shore Harvard Medical School Fellowship"},{"name":"Andrew P. Merrill Memorial Research Fellowship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbr.2017.05.063","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T00:32:14Z","timestamp":1496536334000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking \u03b12-containing GABAA receptors"],"prefix":"10.1016","volume":"332","author":[{"given":"Rebecca S.","family":"Benham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishani B.","family":"Hewage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond F.","family":"Suckow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Engin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2017.05.063_bib0005","series-title":"The Global Burden of Disease: 2004 update","first-page":"1","author":"WHO","year":"2004"},{"key":"10.1016\/j.bbr.2017.05.063_bib0010","first-page":"6","article-title":"Depression: a global public health concern","author":"Marcus","year":"2012","journal-title":"World Federation Mental Health"},{"key":"10.1016\/j.bbr.2017.05.063_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2010.10.004","article-title":"Stuck in a rut: rethinking depression and its treatment","volume":"34","author":"Holtzheimer","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0025","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","article-title":"Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy","volume":"56","author":"Sanacora","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2008.10.025","article-title":"Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder","volume":"65","author":"Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"L\u00fcscher","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"Gaba(a) receptor channels","volume":"17","author":"Macdonald","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0166-2236(88)90156-7","article-title":"Electrophysiology of GABAA and GABAB receptor subtypes","volume":"11","author":"Bormann","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbr.2017.05.063_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2013.01.008","article-title":"Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain","volume":"236","author":"H\u00f6rtnagl","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2017.05.063_bib0065","doi-asserted-by":"crossref","first-page":"e6585","DOI":"10.1371\/journal.pone.0006585","article-title":"Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression","volume":"4","author":"Sequeira","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2017.05.063_bib0070","doi-asserted-by":"crossref","first-page":"12213","DOI":"10.1073\/pnas.2131679100","article-title":"Repeated neonatal handling with maternal separation permanently alters hippocampal GABAA receptors and behavioral stress responses","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2017.05.063_bib0075","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1523\/JNEUROSCI.4945-06.2007","article-title":"Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress","volume":"27","author":"Maguire","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2007.08.077","article-title":"Evidence for a role of GABAA receptor in the acute restraint stress-induced enhancement of spatial memory","volume":"1181","author":"Zheng","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2017.05.063_bib0085","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/12207","article-title":"Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues","volume":"2","author":"Crestani","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0090","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.biopsych.2010.04.024","article-title":"gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression","volume":"68","author":"Shen","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0095","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1523\/JNEUROSCI.3609-06.2007","article-title":"GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states","volume":"27","author":"Earnheart","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0100","doi-asserted-by":"crossref","first-page":"16616","DOI":"10.1523\/JNEUROSCI.1720-12.2012","article-title":"Direct alteration of a specific inhibitory circuit of the hippocampus by antidepressants","volume":"32","author":"M\u00e9ndez","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.102.044834","article-title":"Fluoxetine increases GABA(A) receptor activity through a novel modulatory site","volume":"304","author":"Robinson","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.05.063_bib0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2017.05.063_bib0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2010.10.009","article-title":"Antidepressant-like properties of \u03b12-containing GABA(A) receptors","volume":"217","author":"Vollenweider","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2017.05.063_bib0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pbb.2012.10.004","article-title":"Dissecting the role of diazepam-sensitive \u03b3-aminobutyric acid type A receptors in defensive behavioral reactivity to mild threat","volume":"103","author":"Koester","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2017.05.063_bib0125","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2017.05.063_bib0130","unstructured":"D. Blumstein, J. Daniel, C. Evans, eds., JWatcher Software, 2012. http:\/\/www.jwatcher.ucla.edu\/ . (Accessed 4 February 2016)."},{"key":"10.1016\/j.bbr.2017.05.063_bib0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00181937","article-title":"The effects of chronic antidepressant treatment in an animal model of anxiety","volume":"95","author":"Bodnoff","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2017.05.063_bib0140","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1001\/archpsyc.1982.04290120049010","article-title":"Desipramine plasma concentration and antidepressant response","volume":"39","author":"Nelson","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0145","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1176\/ajp.153.11.1450","article-title":"Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder","volume":"153","author":"Koran","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0150","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0269881109106927","article-title":"Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics","volume":"24","author":"Nutt","year":"2010","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.bbr.2017.05.063_bib0155","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","article-title":"Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder","volume":"59","author":"Fava","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0160","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1523\/JNEUROSCI.0214-12.2012","article-title":"Early formation of GABAergic synapses governs the development of adult-born neurons in the olfactory bulb","volume":"32","author":"Pallotto","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2004.02.033","article-title":"Depression: a case of neuronal life and death","volume":"56","author":"Duman","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0170","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2017.05.063_bib0175","series-title":"US Food and Drug Administration Public Health Advisory Subject: Worsening depression and suicidality in patients being treated with antidepressant medications., U.S. Food and Drug Administration","year":"2004"},{"key":"10.1016\/j.bbr.2017.05.063_bib0180","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.292.3.338","article-title":"Antidepressants and the risk of suicidal behaviors","volume":"292","author":"Jick","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bbr.2017.05.063_bib0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0190","article-title":"Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment","author":"Alboni","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0195","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/mp.2008.81","article-title":"Association of childhood trauma exposure and GABRA2 polymorphisms with risk of posttraumatic stress disorder in adults","volume":"14","author":"Nelson","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2017.05.063_bib0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-4-12","article-title":"Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine","volume":"4","author":"Kobayashi","year":"2011","journal-title":"Mol. Brain"}],"updated-by":[{"DOI":"10.1016\/j.bbr.2017.10.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000}}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816310804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816310804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:09:55Z","timestamp":1759064995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816310804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"alternative-id":["S0166432816310804"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.05.063","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking \u03b12-containing GABAA receptors","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}